Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to 0.1%.

  • Utah Medical Products' Return on Capital Employed fell 200.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.02% for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Utah Medical Products' Return on Capital Employed is 0.1%, which was down 200.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Return on Capital Employed registered a high of 0.18% during Q3 2022, and its lowest value of 0.1% during Q3 2025.
  • In the last 5 years, Utah Medical Products' Return on Capital Employed had a median value of 0.14% in 2023 and averaged 0.14%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -400bps in 2021, then surged by 500bps in 2022.
  • Utah Medical Products' Return on Capital Employed (Quarter) stood at 0.17% in 2021, then grew by 4bps to 0.17% in 2022, then decreased by -24bps to 0.13% in 2023, then decreased by -15bps to 0.11% in 2024, then decreased by -10bps to 0.1% in 2025.
  • Its Return on Capital Employed was 0.1% in Q3 2025, compared to 0.11% in Q2 2025 and 0.11% in Q1 2025.